
Charanjit Aulakh
Examiner (ID: 11601)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1203, 1621 |
| Total Applications | 3765 |
| Issued Applications | 2855 |
| Pending Applications | 383 |
| Abandoned Applications | 582 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11895178
[patent_doc_number] => 09765103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Cleavable conjugates of functionalized platinum-acridine and platinum-benzacridine agents and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 15/321578
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15284
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321578
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/321578 | Cleavable conjugates of functionalized platinum-acridine and platinum-benzacridine agents and methods thereof | Jun 21, 2015 | Issued |
Array
(
[id] => 11506185
[patent_doc_number] => 09597327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-21
[patent_title] => 'Synthesis of (R)-N-methylnaltrexone'
[patent_app_type] => utility
[patent_app_number] => 14/746513
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 22598
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14746513
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/746513 | Synthesis of (R)-N-methylnaltrexone | Jun 21, 2015 | Issued |
Array
(
[id] => 10399561
[patent_doc_number] => 20150284569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'BORON CONTAINING PERYLENE MONOIMIDES, A PROCESS FOR THEIR PRODUCTION, THEIR USE AS BUILDING BLOCKS FOR THE PRODUCTION OF PERYLENE MONOIMIDE DERIVATIVES, MONOIMIDE DERIVATIVES AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/746113
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15303
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14746113
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/746113 | Boron containing perylene monoimides, a process for their production, their use as building blocks for the production of perylene monoimide derivatives, monoimide derivatives and their use in dye-sensitized solar cells | Jun 21, 2015 | Issued |
Array
(
[id] => 10402926
[patent_doc_number] => 20150287935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES'
[patent_app_type] => utility
[patent_app_number] => 14/744535
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 23872
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744535
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/744535 | Organic electroluminescent materials and devices | Jun 18, 2015 | Issued |
Array
(
[id] => 11593067
[patent_doc_number] => 20170117479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'N-FLUOROALKYL-SUBSTITUTED DIBROMONAPHTHALENE DIIMIDES AND THEIR USE AS SEMICONDUCTOR'
[patent_app_type] => utility
[patent_app_number] => 15/318566
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14259
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15318566
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/318566 | N-fluoroalkyl-substituted dibromonaphthalene diimides and their use as semiconductor | Jun 15, 2015 | Issued |
Array
(
[id] => 11925908
[patent_doc_number] => 09793499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Organic iridium complex for organic electroluminescent element'
[patent_app_type] => utility
[patent_app_number] => 15/314648
[patent_app_country] => US
[patent_app_date] => 2015-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12208
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314648
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314648 | Organic iridium complex for organic electroluminescent element | Jun 8, 2015 | Issued |
Array
(
[id] => 10380591
[patent_doc_number] => 20150265598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'Oxycodone Compositions'
[patent_app_type] => utility
[patent_app_number] => 14/725210
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17667
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14725210
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/725210 | Oxycodone Compositions | May 28, 2015 | Abandoned |
Array
(
[id] => 10380590
[patent_doc_number] => 20150265597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'Oxycodone Compositions'
[patent_app_type] => utility
[patent_app_number] => 14/725153
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17661
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14725153
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/725153 | Oxycodone compositions | May 28, 2015 | Issued |
Array
(
[id] => 10373080
[patent_doc_number] => 20150258086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'Oxycodone Compositions'
[patent_app_type] => utility
[patent_app_number] => 14/725110
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17660
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14725110
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/725110 | Oxycodone Compositions | May 28, 2015 | Abandoned |
Array
(
[id] => 10800658
[patent_doc_number] => 20160146814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'Fluorogenic/Fluorescent Probes Derivative from Sulfoxanthene, and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/720017
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11375
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14720017
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/720017 | Fluorogenic/fluorescent probes derivative from sulfoxanthene, and use thereof | May 21, 2015 | Issued |
Array
(
[id] => 11635055
[patent_doc_number] => 09657014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Substituted 1,6-naphthyridines'
[patent_app_type] => utility
[patent_app_number] => 14/717109
[patent_app_country] => US
[patent_app_date] => 2015-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32389
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14717109
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/717109 | Substituted 1,6-naphthyridines | May 19, 2015 | Issued |
Array
(
[id] => 10621616
[patent_doc_number] => 09340553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR'
[patent_app_type] => utility
[patent_app_number] => 14/714484
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 63461
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14714484
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/714484 | Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR | May 17, 2015 | Issued |
Array
(
[id] => 10613768
[patent_doc_number] => 09333195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Quinuclidine derivatives and medicinal compositions containing the same'
[patent_app_type] => utility
[patent_app_number] => 14/712866
[patent_app_country] => US
[patent_app_date] => 2015-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27741
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14712866
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/712866 | Quinuclidine derivatives and medicinal compositions containing the same | May 13, 2015 | Issued |
Array
(
[id] => 10451961
[patent_doc_number] => 20150336976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'DIPICOLYLAMINE DERIVATIVES AND THEIR PHARMACEUTICAL USES'
[patent_app_type] => utility
[patent_app_number] => 14/711946
[patent_app_country] => US
[patent_app_date] => 2015-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17410
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711946
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/711946 | Dipicolylamine derivatives and their pharmaceutical uses | May 13, 2015 | Issued |
Array
(
[id] => 10361913
[patent_doc_number] => 20150246917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'INHIBITORS OF HEPATITIS C VIRUS REPLICATION'
[patent_app_type] => utility
[patent_app_number] => 14/711345
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53238
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711345
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/711345 | INHIBITORS OF HEPATITIS C VIRUS REPLICATION | May 12, 2015 | Abandoned |
Array
(
[id] => 14031207
[patent_doc_number] => 10227342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Heteroaryl compounds for kinase inhibition
[patent_app_type] => utility
[patent_app_number] => 15/319637
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68139
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 461
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319637
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319637 | Heteroaryl compounds for kinase inhibition | May 12, 2015 | Issued |
Array
(
[id] => 10587837
[patent_doc_number] => 09309440
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-04-12
[patent_title] => 'Electroactive polymer based supercapacitors including a cathode having BBL or Pyr-BBL'
[patent_app_type] => utility
[patent_app_number] => 14/709758
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13035
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709758
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/709758 | Electroactive polymer based supercapacitors including a cathode having BBL or Pyr-BBL | May 11, 2015 | Issued |
Array
(
[id] => 11304736
[patent_doc_number] => 09512123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Compositions, uses and methods for making them'
[patent_app_type] => utility
[patent_app_number] => 14/708230
[patent_app_country] => US
[patent_app_date] => 2015-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36510
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14708230
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/708230 | Compositions, uses and methods for making them | May 8, 2015 | Issued |
Array
(
[id] => 11836153
[patent_doc_number] => 20170217872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Method for the preparation of Intermediates for carboxy-fluoresceins and novel carboxy-fluorescein'
[patent_app_type] => utility
[patent_app_number] => 15/330787
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10362
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15330787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/330787 | Method for the preparation of Intermediates for carboxy-fluoresceins and novel carboxy-fluorescein | May 5, 2015 | Abandoned |
Array
(
[id] => 11755952
[patent_doc_number] => 20170202818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'METHODS AND COMPOSITIONS TO MODIFY GSK-3 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/326782
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 31362
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326782 | METHODS AND COMPOSITIONS TO MODIFY GSK-3 ACTIVITY | May 5, 2015 | Abandoned |